Microbot Medical Inc. (MBOT)Healthcare | Medical Instruments & Supplies | Hingham, United States | NasdaqCM
1.89 USD
+0.00
(0.268%)
⇧
(July 14, 2026, 9:38 a.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 4:31 a.m. EDT
The investment case here is defined by a stark contradiction between a catastrophic long-term reality and a speculative short-term narrative. Fundamentally, the business is in freefall; the stock has lost 95% of its value over the last nine years, and the company is burning cash with negative operating margins and no history of paying dividends. Despite recent headlines celebrating a 100% revenue jump in a single quarter, the multi-year trajectory shows six years of decline versus only three of growth, leaving the company with no proven track record of sustained profitability or survival. The balance sheet, while currently debt-light, cannot mask the structural deterioration evident in the price action. However, the short-term outlook is driven entirely by options speculation rather than operational success. Traders are positioning for a dramatic rebound, evidenced by heavy call open interest at the $5.00 level—a target requiring the stock to nearly triple from current prices. This suggests a belief that the LIBERTY robot adoption will trigger a rapid re-rating. Yet, this optimism is tempered by significant put buying, which acts as a hedge against the very high probability of continued stagnation or further decline. With a low-confidence statistical forecast and no dividend safety net, the stock remains a high-risk gamble on a turnaround story that has failed to materialize over the last decade. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.062203 |
| AutoARIMA | 0.114687 |
| AutoETS | 0.115067 |
| MSTL | 0.128418 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 0.14 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.346 |
| Excess Kurtosis | -0.90 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1.212 |
| Revenue per Share | 0.002 |
| Market Cap | 126,605,648 |
| Forward P/E | -6.35 |
| Beta | 1.04 |
| Website | https://microbotmedical.com |
As of July 11, 2026, 4:31 a.m. EDT: Speculators are heavily skewed toward calls, with open interest concentrated significantly out-of-the-money at the $5.00 strike across multiple expirations, suggesting a speculative bet on a massive recovery. However, this bullish positioning is offset by substantial put volume and open interest at lower strikes ($1.00-$2.00), indicating a 'long gamma' environment where traders are hedging against further downside while hoping for a volatile bounce. The implied volatility is elevated, reflecting uncertainty rather than a clear directional consensus.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.24497992 |
| Address1 | 175 Derby Street |
| Address2 | Bld. 27 |
| All Time High | 324,000.0 |
| All Time Low | 0.82 |
| Ask | 2.41 |
| Ask Size | 2 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 809,800 |
| Average Daily Volume3 Month | 1,398,100 |
| Average Volume | 1,398,100 |
| Average Volume10Days | 809,800 |
| Beta | 1.036 |
| Bid | 1.35 |
| Bid Size | 2 |
| Book Value | 1.103 |
| City | Hingham |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.885 |
| Current Ratio | 22.595 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 1.89 |
| Day Low | 1.86 |
| Debt To Equity | 1.212 |
| Display Name | Microbot Medical |
| Dividend Date | 1,536,105,600 |
| Earnings Timestamp End | 1,755,518,400 |
| Earnings Timestamp Start | 1,754,996,340 |
| Ebitda | -15,998,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -3.417 |
| Enterprise To Revenue | 520.646 |
| Enterprise Value | 54,667,824 |
| Eps Current Year | -0.28 |
| Eps Forward | -0.29667 |
| Eps Trailing Twelve Months | -0.26 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.9088 |
| Fifty Day Average Change | -0.023800015 |
| Fifty Day Average Change Percent | -0.012468575 |
| Fifty Two Week Change Percent | -24.497992 |
| Fifty Two Week High | 4.67 |
| Fifty Two Week High Change | -2.785 |
| Fifty Two Week High Change Percent | -0.5963597 |
| Fifty Two Week Low | 1.6 |
| Fifty Two Week Low Change | 0.28499997 |
| Fifty Two Week Low Change Percent | 0.17812498 |
| Fifty Two Week Range | 1.6 - 4.67 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 701,533,800,000 |
| Float Shares | 67,164,801 |
| Forward Eps | -0.29667 |
| Forward P E | -6.3538613 |
| Free Cashflow | -11,616,250 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 43 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.01905 |
| Gross Profits | 2,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0 |
| Held Percent Institutions | 0.2176 |
| Implied Shares Outstanding | 67,164,801 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Ir Website | http://investor.stemcellsinc.com/phoenix.zhtml?c=86230&p=irol-irhome |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,536,105,600 |
| Last Split Factor | 1:15 |
| Long Business Summary | Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body's vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts |
| Long Name | Microbot Medical Inc. |
| Market | us_market |
| Market Cap | 126,605,648 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_130942378 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -14,212,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 126,605,649 |
| Number Of Analyst Opinions | 3 |
| Open | 1.88 |
| Operating Cashflow | -15,225,000 |
| Operating Margins | -41.14286 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.7 |
| Phone | 781 875 3605 |
| Previous Close | 1.88 |
| Price Eps Current Year | -6.732143 |
| Price Hint | 4 |
| Price To Book | 1.7089754 |
| Price To Sales Trailing12 Months | 1,205.7681 |
| Profit Margins | 0.0 |
| Quick Ratio | 21.436 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | 0.004999995 |
| Regular Market Change Percent | 0.26811063 |
| Regular Market Day High | 1.89 |
| Regular Market Day Low | 1.86 |
| Regular Market Day Range | 1.86 - 1.89 |
| Regular Market Open | 1.88 |
| Regular Market Previous Close | 1.88 |
| Regular Market Price | 1.885 |
| Regular Market Time | 1,784,036,299 |
| Regular Market Volume | 18,649 |
| Return On Assets | -0.18404 |
| Return On Equity | -0.27581 |
| Revenue Per Share | 0.002 |
| Sand P52 Week Change | 0.20365608 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 67,164,801 |
| Shares Percent Shares Out | 0.1094 |
| Shares Short | 7,349,099 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 7,640,438 |
| Short Name | Microbot Medical Inc. |
| Short Percent Of Float | 0.1096 |
| Short Ratio | 7.95 |
| Source Interval | 15 |
| State | MA |
| Symbol | MBOT |
| Target High Price | 12.0 |
| Target Low Price | 4.0 |
| Target Mean Price | 7.0 |
| Target Median Price | 5.0 |
| Total Cash | 72,500,000 |
| Total Cash Per Share | 1.079 |
| Total Debt | 898,000 |
| Total Revenue | 105,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.26 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 2.2275 |
| Two Hundred Day Average Change | -0.34249997 |
| Two Hundred Day Average Change Percent | -0.1537598 |
| Type Disp | Equity |
| Volume | 18,649 |
| Website | https://microbotmedical.com |
| Zip | 2,043 |